Hydrogel maker United-Guardian's Q2 sales rise on cosmetic ingredient demand

Overview

• U.S. specialty ingredients maker's Q2 net sales rose 10% yr/yr, net income up 16%

• Growth driven by increased cosmetic ingredient sales, mainly from Ashland Specialty Ingredients

• Pharmaceutical sales rose 1% in Q2, with Renacidin as main growth driver

Outlook

• United-Guardian says it is focused on expanding promotional efforts for Renacidin in 2026

Result Drivers

• COSMETIC INGREDIENT SALES - Co said Q2 cosmetic ingredient sales rose 44%, mainly due to resumed regular purchasing by Ashland Specialty Ingredients after inventory reductions in 2025

• PHARMACEUTICAL SALES - Q2 pharmaceutical sales rose 1%, with Renacidin cited as the primary growth driver

Company press release: ID:nGNX5XcFS6

Key Details

Reuters Recommended Reads

• Aug 5 - e.l.f. Beauty beats Q1 revenue estimates on retail, e-commerce strength; lifts 2027 FY guidance

• Aug 4 - Flavors and fragrances maker IFF's Q2 sales rise 2%, unveils $2.5 bln buyback

• Aug 7 - Calumet Q2 sales beat estimates on demand for specialty products

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)